Literature DB >> 9012576

Monitoring of cerebral hemodynamics with jugular bulb catheters.

Z Feldman1, C S Robertson.   

Abstract

Jugular venous oxygen saturation (SjvO2) monitoring is useful for detecting episodes of cerebral hypoxia/ischemia in patients with head injury, patients undergoing neurosurgical procedures, and patients undergoing cardiopulmonary bypass. The use of SjvO2 monitoring can direct the treatment of ischemic episodes and identify the optimal level of cerebral perfusion pressure and PCO2 for the individual patient.

Entities:  

Mesh:

Year:  1997        PMID: 9012576     DOI: 10.1016/s0749-0704(05)70296-7

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  5 in total

1.  Significance of a reduced cerebral blood flow during the first 12 hours after traumatic brain injury.

Authors:  Roman Hlatky; Charles F Contant; Pedro Diaz-Marchan; Alex B Valadka; Claudia S Robertson
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Comparison of Propofol and Sevoflurane on Cerebral Oxygenation Using Juglar Venous Oximetery (SjVo2) in Patients Undergoing Surgery for Traumatic Brain Injury.

Authors:  Rajeev Chauhan; Nidhi Panda; Hemant Bhagat; Neerja Bharti; Ankur Luthra; Shiv Lal Soni; Narender Kaloria; Praveen Salunke; Vishwanath Bhaire; Summit Dev Bloria
Journal:  Asian J Neurosurg       Date:  2020-08-28

Review 3.  Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit.

Authors:  Peter Le Roux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 4.  Multimodal brain monitoring in fulminant hepatic failure.

Authors:  Fernando Mendes Paschoal; Ricardo Carvalho Nogueira; Karla De Almeida Lins Ronconi; Marcelo de Lima Oliveira; Manoel Jacobsen Teixeira; Edson Bor-Seng-Shu
Journal:  World J Hepatol       Date:  2016-08-08

5.  Should We Monitor ScVO(2) in Critically Ill Patients?

Authors:  Sophie Nebout; Romain Pirracchio
Journal:  Cardiol Res Pract       Date:  2011-09-21       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.